Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
In the latest session, Bausch Health Companies Inc (NYSE: BHC) closed at $4.32 down -1.14% from its previous closing price of $4.37. In other words, the price has decreased by -$1.14 from its previous closing price. On the day, 2.28 million shares were traded. BHC stock price reached its highest trading level at $4.4491 during the session, while it also had its lowest trading level at $4.25.
Ratios:
For a deeper understanding of Bausch Health Companies Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 1.33 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 1.30. For the most recent quarter (mrq), Quick Ratio is recorded 0.62 and its Current Ratio is at 0.86.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Piper Sandler on August 02, 2024, Downgraded its rating to Underweight and sets its target price to $3 from $9 previously.
On July 10, 2024, Raymond James started tracking the stock assigning a Mkt Perform rating and target price of $8.
Jefferies Upgraded its Hold to Buy on September 20, 2023, whereas the target price for the stock was revised from $9 to $16.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Dec 02 ’24 when Carson Seana sold 440 shares for $8.35 per share. The transaction valued at 3,674 led to the insider holds 433,066 shares of the business.
Carson Seana bought 440 shares of BHC for $3,674 on Dec 02 ’24. On Sep 06 ’24, another insider, Carson Seana, who serves as the EVP, General Counsel of the company, sold 13,370 shares for $6.21 each. As a result, the insider received 83,028 and left with 435,198 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BHC now has a Market Capitalization of 1596296192 and an Enterprise Value of 23204474880. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.17. Its current Enterprise Value per Revenue stands at 2.411 whereas that against EBITDA is 7.404.
Stock Price History:
The Beta on a monthly basis for BHC is 0.48, which has changed by -0.49942064 over the last 52 weeks, in comparison to a change of 0.059571505 over the same period for the S&P500. Over the past 52 weeks, BHC has reached a high of $9.87, while it has fallen to a 52-week low of $3.96. The 50-Day Moving Average of the stock is -35.04%, while the 200-Day Moving Average is calculated to be -40.34%.
Shares Statistics:
For the past three months, BHC has traded an average of 2.87M shares per day and 3104400 over the past ten days. A total of 367.84M shares are outstanding, with a floating share count of 291.56M. Insiders hold about 21.10% of the company’s shares, while institutions hold 59.36% stake in the company. Shares short for BHC as of 1743379200 were 7852454 with a Short Ratio of 2.73, compared to 1740700800 on 6449195. Therefore, it implies a Short% of Shares Outstanding of 7852454 and a Short% of Float of 2.3.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0The stock’s 5-year Average Dividend Yield is 6.52.
